Shares of Square Inc (NYSE: SQ) have gained around 28% year to date.
Although the gradual reopening of the U.S. economy may be an incremental positive for brick-and-mortar merchants, small- and mid-sized companies have yet to witness a trough in churn, according to BofA Securities.
The Square Analyst
Jason Kupferberg downgraded Square from Buy to Underperform with an unchanged $84 price target.
The Square Thesis
While stimulus funds may provide temporary relief, a significant number of small- and mid-sized businesses may struggle to remain afloat, especially if the economy reopens only partially, Kupferberg said in the Monday downgrade note. (See his track record here.)
Around 75% of Square’s payment volume comes from merchants with less than $500,000 in annual card volume, the analyst said. Despite this backdrop, the stock has outperformed the S&P500 by around 4,000 basis points so far this year, he said.
Although the consumer-facing Cash App business is performing well, the Seller segment represents around 70% of the company, Kupferberg said.
The reopening of the US economy is uneven, creating uncertainty around a recovery in Square’s gross payment volume, which the analyst said “will likely vary significantly across a range of spending categories.”
While expressing optimism over Square’s competitive positioning in the long-term, BofA said wrote the stock “has moved too far and too fast relative to its near-term fundamental prospects.”
SQ Price Action
Shares of Square were down 2.18% at $78.51 at the time of publication.
Along With Dramatic Jobs Data, Investors Scrutinize Recent Earnings From Uber, Square
10 Biggest Price Target Changes For Friday
Photo courtesy of Square.
Latest Ratings for SQ
|May 2020||Stephens & Co.||Downgrades||Overweight||Equal-Weight|
|May 2020||B of A Securities||Downgrades||Buy||Underperform|
View More Analyst Ratings for SQ
View the Latest Analyst Ratings
See more from Benzinga
- Coca-Cola CFO Says Trough Will Come In Q2, Says Bullish Credit Suisse
- BofA Downgrades Canada Goose On Projected Revenue Decline
- Cantor Cuts Canopy Growth Target After Warrants Exercise
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.